Our study revealed that miR-146a expression level decreased significantly in IBD patients than controls, and the decrease was associated with disease activity in contrast to fecal calprotectin, CRP, and ESR, which significantly increased with disease activity. The gene discussed is CRP; the disease is inflammatory bowel disease.